$HIMS investors are about to go on a generational run.
And it will be earned through their own conviction, patience and individual effort.
This thing is just getting started.
Not even 0.1% of the thesis has played out yet.
The past year has been insanely volatile, but it has sharpened us.
Better investors.
Stronger conviction.
Clearer thinking.
This is only the beginning.
Anduril's co-founder Joe is Taiwanese !!
拉奇:因中國侵略性創辦Anduril 盼台科技優勢持續
@PalmerLuckey : Founded @anduriltech Due to China's Aggression; Hopes Taiwan's Technological Advantage Continues
(CNA reporter Wu Shu-wei, Taipei, 4th)
Palmer Luckey, founder of the American defense technology company Anduril—which has been sanctioned by China due to arms sales to Taiwan—stated today that one of the reasons for founding Anduril was China's increasing aggression and its manipulation of the global economy and culture. He noted that Taiwan is a global leader in the technology sector and that he does not want to see this advantage disappear.
Luckey is currently visiting Taiwan to participate in COMPUTEX. During his interview with CNA this afternoon, it coincided with the news that the Altius-600M drones, produced by Anduril and purchased by Taiwan from the United States, successfully struck maritime targets in Yilan for the first time yesterday with a 100% hit rate.
Luckey stated that his visit to Taiwan is to meet with current and potential partners. Currently, Anduril's supply chain includes approximately 30 Taiwanese manufacturers, and the number of partner companies continues to grow.
In December last year, the Chinese government announced countermeasures against 20 U.S. defense-related companies and 10 senior executives involved in "arming Taiwan" in recent years, with Luckey among those named. Anduril Industries had already been placed on China's "Unreliable Entities List" for sanctions early last year.
Regarding the impact of the Chinese sanctions, Luckey stated that aside from being unable to visit China or Hong Kong, transit through these locations, or fly on Chinese-owned or invested airlines, there have been no other real negative effects. "I've always wanted to be sanctioned [by China]," he said.
Luckey recalled that after then-U.S. House Speaker Nancy Pelosi visited Taiwan in August 2022 and was subsequently sanctioned by China, he complained to friends that "it wasn't fair" because he felt he had done more for Taiwan than Pelosi had. Consequently, he made being sanctioned by China a goal. Now that China has labeled him a "radical separatist terrorist," he has framed the sanction notice and hung it on his wall, treating it as a badge of honor.
Luckey pointed out that one of the reasons for founding Anduril was China's increasing aggression and its manipulation of economies and cultures around the world. While working in Silicon Valley, he witnessed firsthand how tech companies were blinded by China, mistakenly believing it would be the next major market.
Luckey founded the virtual reality company Oculus VR at the age of 19 and sold it to Facebook for $2 billion in 2014. In past interviews, Luckey has mentioned visiting Shenzhen and other locations in China numerous times.
Regarding his experience dealing with China, Luckey shared that China has built a very powerful production machine; if one lacks ideology or national loyalty, China is an excellent place to manufacture products. However, he had already personally experienced how the Chinese government's operations and values differ drastically from those of Western countries. During past business trips to China, samples left in his hotel room were frequently stolen, and on one occasion, a sample he received was actually fitted with a bug capable of transmitting via radio.
Luckey said that in the United States, such incidents would be immediately reported to the FBI, but in China, calling the police is useless because officials will not stop the theft of intellectual property—in fact, the government might even be involved. He experienced this firsthand and quickly had enough.
Luckey stated that many of the displays and semiconductors for Oculus products came from Taiwan. Through this, he realized that Taiwan holds a unique position in the global technology industry and leads the rest of the world. He noted that some things in the world exist only because Taiwan is a leader in the tech field, adding, "I don't want that advantage to disappear."
Luckey, who visited Taiwan many times in the past for Oculus business, said this is his fourth visit on behalf of Anduril. His personal connection to Taiwan goes even further; he revealed that one of Anduril's co-founders, Joe Chen, is Taiwanese and recently accompanied his mother back to Taiwan.
"So you know, it's like if you have a Ukrainian friend, you might not like Russia very much," Luckey said, noting the logic is the same.
Today, we closed our acquisition of Eucalyptus, advancing our position as the world’s largest consumer health platform.
When @_Timdoyle and I first met, healthcare looked very different (and so did our lives - I was a first-time dad, still on paternity leave when we had our first lunch). Proactive healthcare still felt niche and the concept of direct-to-consumer access was misunderstood as a trend.
Five years later, the world has changed (and so has life – I’m now a dad to three boys, and Tim’s a father, too). People are no longer willing to navigate through arbitrary barriers for the simplest kinds of care. Healthcare innovators like drugmakers and diagnostic companies have realized connecting directly with individuals is the most powerful way to grow.
But what has stayed the same is how aligned Tim and I are on what the future of health can and should be. It’s simple, deeply personal, and built for everyday life. It became clear at the end of last year that the time has never been more right to come together.
Today, we’re operating as one company, focused on reaching millions of people around the world with a version of health that feels like a luxury, but doesn’t cost like one. Combining Eucalyptus’ local expertise with our scale means we can serve millions of people around the world and expand the network effects of the platform. We’ll become an everyday health companion and a partner to other healthcare innovators who want to build long-term relationships with their customers.
I told the entire team this morning: The most enduring consumer companies are the ones that create a completely new way of experiencing the most personal parts of our lives. My kids deserve a different version of health than I got. So do Tim’s. So do yours. That’s what we’re building at Hims & Hers and I can’t wait for the world to see what’s possible.
https://t.co/XIampqFSST
Read more here, including important footnotes and disclaimers: https://t.co/4A919nDjTO
My view is $PLTR is extremely cheap right now
People will not believe you could buy at $130 a few years from now
Free cash flow per share is going vertical
Ahead of COMPUTEX, the two most important CEOs on the planet right now Jensen Huang and TSMC CEO C.C. Wei, having dinner together and celebrating decades long partnership
FYI, $NVDA accounted for 20% of $TSMC revenue $40B dollars and they don’t have a a single legal agreement 🤯
I can't believe I'm posting this, but it's true and funny so here we go.
@shai_wininger appeared to me in a dream last night urging me to buy as much $LMND as possible "before it's too late."
I spoke with @washingtonpost about what’s coming next for us, and we covered everything from GLP-1s to supplements to biological age to peptides. But the bigger picture is how we can create better access to the things that can help anyone feel great.
Thanks @PostRowland for a great conversation about what’s coming next in health and how we’re building it at Hims & Hers.
Yesterday, we raised $350M from a wide range of high-caliber institutional investors who believe in the long-term vision of what we’re building.
It was more than we set out to raise, and it tells me that the industry believes in the value of our model and the impact of our platform. Given the terms we received, it's clear that our investors are taking a high-conviction view of our strategy.
This offering was designed to keep us flexible and is structured to minimize dilution, while giving us an efficient way to scale aggressively, interest-free, across strategic areas: global growth, infrastructure, and AI-power customer tools.
All of that is how we’re positioning ourselves to keep growing this year and make progress towards our ambitious long-term targets. More than that, though, it is part of how we’ll help more people do a simple but life-changing thing: just feel great.
https://t.co/fhPtm0gA7Z
$pltr expects to grow 100% yearly now and I hope that you understood this when I shouted from the rooftops
this is a 20 trillion dollar company in the making
not understanding this is the most costly thing you will do in your life
Palantir reports Q1 ‘26 U.S. revenue growth of 104% Y/Y and revenue growth of 85% Y/Y; raises FY ’26 revenue guidance to 71% Y/Y growth and U.S. comm revenue guidance to 120% Y/Y, crushing consensus expectations.
Q1 U.S. commercial revenue grew 133% y/y and adjusted operating margin was 60%.
We also generated $871 million in Q1 2026 GAAP net income, representing 53% margin and 307% Y/Y growth.
Lemonade’s Q1 results are 🔥. So much to share, where do I start?
First, get into the AI mood, click this, + volume ⏫
https://t.co/IDPCvrTHge (by @kidfrancescoli)
🚀10th consecutive quarter of accelerating IFP growth
🔥 Topline at $1.33 Billion (IFP +32%)
🔥 Revenue grew 71% to $258M
🔥 Gross Profit increased 159% to $100M
🔥 3.14M Customers
🔥 Adj. Free Cash Flow $17M
Lemonade Pet exploding!
✅ Surpassed $500M top line early in Q2
✅ #1 most searched pet insurance brand in the U.S.
✅ @lemonade_inc is now the 4th largest pet carrier in the U.S.
✅ AI-powered automation drives record claim handling efficiency (LAE: ~4%)
✅ Our data + tech edge lets us lower prices while boosting profitability
Car picking up speed
✅ Now at 60% YoY growth, $214M IFP
✅ Loss ratio improved to 74% (14 pts better YoY)
✅ Autonomous Car for @Tesla FSD conversion rate 70% higher than standard
And more...
↗️ Raising 2026 top & bottom line guidance
↗️ IFP per employee > $1M (3x improvement in 4 years)
↗️ Positive Adj. EBITDA in Q4
↗️ Investor Day in NYC November 17
As of this morning, providers on our platform can now send prescriptions for Zepbound® vials and KwikPen®, as well as Foundayo™, to the LillyDirect® pharmacy and access self-pay pricing for our customers because of an expansion in our platform’s functionality.
In many ways, today reminds me of Netflix’s early days, when everyone talked about whether they would have the latest blockbuster in their catalog. As if Netflix’s success depended on its ability to become the distribution channel for a single film.
They were missing the forest for the trees: Netflix wasn’t just renting DVDs. It was changing consumer behavior by ruthlessly prioritizing choice and inventing new pathways to the things people wanted the most.
By offering a full range of FDA-approved GLP-1s on our platform, we’re similarly giving our customers more choices through all the tools we have available – and we’ll continue to push here on behalf of everyone who depends on us for their care.
Read more on how we’re making this possible, including important info, here:
https://t.co/HxYN1KhGwS